Literature DB >> 34690147

COVID-19 Case Fatality and Alzheimer's Disease.

Qiang Zhang1, Jordan L Schultz1,2, Georgina M Aldridge1, Jacob E Simmering3, Youngcho Kim1, Amy C Ogilvie2,4, Nandakumar S Narayanan1.   

Abstract

Previous studies have identified dementia as a risk factor for death from coronavirus disease 2019 (COVID-19). However, it is unclear whether Alzheimer's disease (AD) is an independent risk factor for COVID-19 case fatality rate. In a retrospective cohort study, we identified 387,841 COVID-19 patients through TriNetX. After adjusting for demographics and comorbidities, we found that AD patients had higher odds of dying from COVID-19 compared to patients without AD (Odds Ratio: 1.20, 95%confidence interval: 1.09-1.32, p < 0.001). Interestingly, we did not observe increased mortality from COVID-19 among patients with vascular dementia. These data are relevant to the evolving COVID-19 pandemic.

Entities:  

Keywords:  Alzheimer’s disease; Coronavirus disease 2019 (COVID-19); Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2); case fatality; dementia with Lewy bodies; frontotemporal dementia; vascular dementia

Mesh:

Year:  2021        PMID: 34690147      PMCID: PMC8841099          DOI: 10.3233/JAD-215161

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.160


  24 in total

1.  Alzheimer disease and mortality: a 15-year epidemiological study.

Authors:  Mary Ganguli; Hiroko H Dodge; Changyu Shen; Rajesh S Pandav; Steven T DeKosky
Journal:  Arch Neurol       Date:  2005-05

2.  Resilience of Alzheimer's Disease to COVID-19.

Authors:  Jingwen Li; Xi Long; Heqing Huang; Jine Tang; Chunli Zhu; Shaoping Hu; Jing Wu; Jinghong Li; Zhicheng Lin; Nian Xiong
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

3.  Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants.

Authors:  Laith J Abu-Raddad; Hiam Chemaitelly; Adeel A Butt
Journal:  N Engl J Med       Date:  2021-05-05       Impact factor: 91.245

4.  Dementia is an age-independent risk factor for severity and death in COVID-19 inpatients.

Authors:  Ana C Tahira; Sergio Verjovski-Almeida; Sergio T Ferreira
Journal:  Alzheimers Dement       Date:  2021-04-21       Impact factor: 16.655

5.  Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients.

Authors:  Gian Paolo Rossi; Viola Sanga; Matthias Barton
Journal:  Elife       Date:  2020-04-06       Impact factor: 8.140

6.  A systematic review of neurological symptoms and complications of COVID-19.

Authors:  Xiangliang Chen; Sarah Laurent; Finja Schweitzer; Clemens Warnke; Oezguer A Onur; Nina N Kleineberg; Gereon R Fink
Journal:  J Neurol       Date:  2020-07-20       Impact factor: 4.849

7.  Another Decade, Another Coronavirus.

Authors:  Stanley Perlman
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

8.  COVID-19 and diabetes: Can DPP4 inhibition play a role?

Authors:  Gianluca Iacobellis
Journal:  Diabetes Res Clin Pract       Date:  2020-03-26       Impact factor: 5.602

9.  Coronavirus Disease 2019 Case Fatality and Parkinson's Disease.

Authors:  Qiang Zhang; Jordan L Schultz; Georgina M Aldridge; Jacob E Simmering; Nandakumar S Narayanan
Journal:  Mov Disord       Date:  2020-10-15       Impact factor: 9.698

Review 10.  Risk of dementia in patients with atrial fibrillation: Short versus long follow-up. A systematic review and meta-analysis.

Authors:  Marco Zuin; Loris Roncon; Angelina Passaro; Cristina Bosi; Carlo Cervellati; Giovanni Zuliani
Journal:  Int J Geriatr Psychiatry       Date:  2021-05-20       Impact factor: 3.485

View more
  2 in total

1.  Incidence and Outcomes of SARS-CoV-2 Infection in Older Adults Living with Dementia: A Population-Based Cohort Study.

Authors:  Silvia Cascini; Nera Agabiti; Claudia Marino; Anna Acampora; Maria Balducci; Enrico Calandrini; Marina Davoli; Anna Maria Bargagli
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

Review 2.  SARS-CoV-2 and neurodegenerative diseases: what we know and what we don't.

Authors:  Paul Lingor; Antonia F Demleitner; Andreas W Wolff; Emily Feneberg
Journal:  J Neural Transm (Vienna)       Date:  2022-04-17       Impact factor: 3.850

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.